News
STAA
47.30
+1.61%
0.75
Weekly Report: what happened at STAA last week (0415-0419)?
Weekly Report · 1d ago
Weekly Report: what happened at STAA last week (0408-0412)?
Weekly Report · 04/15 09:45
Staar Surg: [Cover]SEC-generated letter
Press release · 04/12 14:03
Apple To $210? Here Are 10 Top Analyst Forecasts For Thursday
JP Morgan cut the price target for Apple Inc. From $215 to $210 on Wednesday. B of A Securities increased NIKE's price target from $110 to $113. Gatos Silver, Inc. Shares fell 2.5% to close at $9.13. Deutsche Bank raised Delta Air Lines' price target.
Benzinga · 04/11 12:31
Staar Surgical Is Maintained at Buy by Mizuho
Dow Jones · 04/11 11:50
Staar Surgical Price Target Raised to $53.00/Share From $45.00 by Mizuho
Dow Jones · 04/11 11:50
STAAR SURGICAL CO <STAA.O>: MIZUHO RAISES TARGET PRICE TO $53 FROM $45
Reuters · 04/11 11:43
Mizuho Maintains Buy on Staar Surgical, Raises Price Target to $53
Benzinga · 04/11 11:39
Analysts Offer Insights on Healthcare Companies: Staar Surgical (STAA), Ocugen (OCGN) and Moderna (MRNA)
TipRanks · 04/09 12:10
U.S. RESEARCH ROUNDUP-CME Group, Danimer Scientific, Intercontinental Exchange
Wall Street analysts revise their ratings and price targets on several U.S.-listed companies. CME Group, Danimer Scientific, Intercontinental Exchange among companies with new targets. American Eagle Outfitters, American Express among those with targets raised. Analysts also raise target prices on American Express, Alcoa and other companies.
Reuters · 04/09 07:12
STAAR SURGICAL CO <STAA.O>: JEFFERIES RAISES TARGET PRICE TO $60 FROM $50
Reuters · 04/09 05:22
Staar Surgical Is Maintained at Hold by Canaccord Genuity
Dow Jones · 04/08 11:57
Canaccord Genuity Maintains Hold on Staar Surgical, Raises Price Target to $46
Benzinga · 04/08 11:47
Weekly Report: what happened at STAA last week (0401-0405)?
Weekly Report · 04/08 09:47
Validea Detailed Fundamental Analysis - STAA
NASDAQ · 04/05 20:07
Strength Seen in Staar Surgical (STAA): Can Its 16.5% Jump Turn into More Strength?
NASDAQ · 04/05 13:15
STAAR Surgical Stock: I Don't See A Great Path Forward, Despite The Recent Surge
STAAR Surgical stock surged by 16.5% after reporting higher than expected preliminary sales for Q1 of fiscal year 2024. The company focuses on the production of implantable lenses for the eye. STAA stock remains expensive compared to similar firms, leading to a 'sell' rating.
Seeking Alpha · 04/05 13:00
STAAR SURGICAL CO <STAA.O>: WILLIAM BLAIR RAISES TO OUTPERFORM
Reuters · 04/05 10:58
Staar Surgical Holds Promise Amid Strong Q1 Performance, Yet Cautious Outlook Justifies Hold Rating
TipRanks · 04/05 10:55
Stocks Slide in Today's Afternoon Trading Session
NASDAQ · 04/04 19:27
More
Webull provides a variety of real-time STAA stock news. You can receive the latest news about Staar Surg through multiple platforms. This information may help you make smarter investment decisions.
About STAA
STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. These lenses provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. The Company is a manufacturer of lenses used worldwide in corrective or refractive surgery. It sells its products in approximately 75 countries, with direct distribution in Japan, Germany, Spain, the United States, Canada, the United Kingdom, and Singapore, with a combination of direct distribution and independent distribution in China, Korea, India, France, Benelux, and Italy. The Company markets and sells ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. The Company’s EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The Company also markets and sells an ICL lens to treat hyperopia (farsightedness), which is called Visian ICL.